← Back to patent-cliff list
CAS 144541-45-7
Methyl (2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoate
Codes：(V)101438-69-a
Application context (from source-drug indications)
乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Cinnamal→(2S,3S)-3-Amino-2-hydroxy-3-phenylpropanamide→Methyl (2S,3S)-3-amino-2-hydroxy-3-phenylpropanoate→alpha-Chlorobenzaldehyde→(4S,5R)-3-Benzoyl-2-[(4-methoxyphenyl)methyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid→Methyl (2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoate→Methyl (2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoate→1-(Dimethoxymethyl)-4-methoxybenzene→Methyl (4S,5R)-3-benzoyl-2-[(4-methoxyphenyl)methyl]-4-phenyl-1,3-oxazolidine-5-carboxylate→(2R,3S)-3-Amino-2-hydroxy-3-phenylpropanoic acid hydrochloride→(2R,3S)-3-Phenylisoserine methyl ester
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.